Cargando…

Health care provider experience with canagliflozin in real-world clinical practice: favorability, treatment patterns, and patient outcomes

PURPOSE: This study describes how health care providers approach canagliflozin for the treatment of patients with type 2 diabetes mellitus (T2DM) in the real world. PATIENTS AND METHODS: An Internet-based questionnaire was completed by 101 endocrinologists, 101 primary care physicians, and 100 nurse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolge, Susan C, Flores, Natalia M, Huang, Shu, Cai, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491699/ https://www.ncbi.nlm.nih.gov/pubmed/28694704 http://dx.doi.org/10.2147/IJGM.S138583

Ejemplares similares

The association of weight loss with patient experience and outcomes in a population of patients with type 2 diabetes mellitus prescribed canagliflozin
por: Gerlanc, Nicole M, et al.
Publicado: (2017)

Predictors and Outcomes of Hospitalization for Influenza: Real-World Evidence from the United States Medicare Population
por: Bolge, Susan C., et al.
Publicado: (2020)

Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study
por: Gorgojo-Martínez, Juan J., et al.
Publicado: (2020)

Short-term outcomes of type 2 diabetes mellitus patients treated with canagliflozin in real-world setting
por: Baruah, Manash P., et al.
Publicado: (2016)

Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis
por: Buysman, Erin K., et al.
Publicado: (2015)

Burden of Pneumonia Among Hospitalized Patients with Influenza: Real-World Evidence from a US Managed Care Population
por: Bolge, Susan C., et al.
Publicado: (2021)

CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice
por: Woo, Vincent, et al.
Publicado: (2018)

The Burden of Poor Mental Well-being Among Patients With Type 2 Diabetes Mellitus: Examining Health Care Resource Use and Work Productivity Loss
por: Bolge, Susan C., et al.
Publicado: (2016)

Canagliflozin – Beginning of the journey
por: Pandey, Sunil Kumar, et al.
Publicado: (2014)

Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program
por: Weir, Matthew R, et al.
Publicado: (2020)

Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan
por: Kadowaki, Takashi, et al.
Publicado: (2022)

Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus
por: Triplitt, Curtis, et al.
Publicado: (2015)

Crystal structure of canagliflozin hemihydrate
por: Liu, Kai-Hang, et al.
Publicado: (2016)

Factors associated with favorable outcomes in acute severe stroke patients: A real-world, national database study
por: Kasemsap, Narongrit, et al.
Publicado: (2022)

Efficacy and Safety of Canagliflozin 300 mg in Overweight and Obese Type 2 Diabetes Mellitus Patients in a Real-world Setting: COLOR Study
por: Aneja, Pankaj, et al.
Publicado: (2019)

Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program
por: Wang, Katherine M., et al.
Publicado: (2021)

Multiple myeloma: patient outcomes in real‐world practice
por: Yong, Kwee, et al.
Publicado: (2016)

Patient profiling in diabetes and role of canagliflozin
por: Amblee, Ambika
Publicado: (2014)

Prolonged diabetic ketoacidosis associated with canagliflozin
por: Sloan, Gordon, et al.
Publicado: (2018)

Repurposing Canagliflozin to target brain aging
por: Jayarathne, Hashan, et al.
Publicado: (2023)

Real-World Use of Alirocumab: Experience from a Large Healthcare Provider
por: Elis, Avishay, et al.
Publicado: (2023)

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
por: Mahaffey, Kenneth W., et al.
Publicado: (2018)

Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice
por: Fonseca, Joaquim
Publicado: (2015)

Real-world experiences: Efficacy and tolerability of pirfenidone in clinical practice
por: Fang, Chuling, et al.
Publicado: (2020)

Practice patterns in pediatric cataract management: Time for real world data
por: Nischal, Ken Kanwal
Publicado: (2017)

Real-world practice patterns of eplerenone use for central serous chorioretinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

Calcaneostop Provides Favorable Short-term Outcomes in Patients With Flexible Flatfoot
por: Ghaznavi, Alireza, et al.
Publicado: (2022)

Sex-dependent effects of canagliflozin and dapagliflozin on hemostasis in normoglycemic and hyperglycemic mice
por: Marcińczyk, Natalia, et al.
Publicado: (2023)

Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance
por: Inagaki, Nobuya, et al.
Publicado: (2021)

An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes
por: Messana, Joseph A, et al.
Publicado: (2017)

Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: A Narrative Review
por: Kruger, Davida, et al.
Publicado: (2020)

Cardiovascular outcomes and mortality after initiation of canagliflozin: Analyses from the EASEL Study
por: Udell, Jacob A., et al.
Publicado: (2019)

Java design patterns: a hands-on experience with real-world examples
por: Sarcar, Vaskaran
Publicado: (2019)

Java design patterns: a hands-on experience with real-world examples
por: Sarcar, Vaskaran
Publicado: (2018)

Canagliflozin and Cardiovascular disease- results of the CANVAS trial
por: Shah, Syed Raza, et al.
Publicado: (2018)

Efficacy and Safety of Canagliflozin in Kidney Transplant Patients
por: Shah, Mita, et al.
Publicado: (2019)

Treatment patterns and outcomes of immunotherapy in extensive‐stage small‐cell lung cancer based on real‐world practice
por: Yang, Yaning, et al.
Publicado: (2022)

Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study
por: Lin, Youwei, et al.
Publicado: (2022)

Practical application of the neuroregenerative properties of ketamine: real world treatment experience
por: Henderson, Theodore A.
Publicado: (2016)

Evaluating real-world treatment patterns and outcomes of mantle cell lymphoma
por: Narkhede, Mayur, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rbopicnc2d81d6qu06u3af24dg